A History of Prescription Drug Monitoring Programs in the United States: Political Appeal and Public Health Efficacy

被引:28
|
作者
Holmgren, A. Jay [1 ]
Botelho, Alyssa [2 ,3 ]
Brandt, Allan M. [3 ,4 ]
机构
[1] Harvard Univ, Harvard Business Sch, Boston, MA 02115 USA
[2] Harvard Med Sch, Med Scientist Training Program, Boston, MA 02115 USA
[3] Harvard Univ, Dept Hist Sci, Cambridge, MA 02138 USA
[4] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA
关键词
IMPLEMENTATION; ADDICTION; DIVERSION; OPIOIDS; LEGAL; NEED;
D O I
10.2105/AJPH.2020.305696
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Prescription drug monitoring programs (PDMPs) have become a widely embraced policy to address the US opioid crisis. Despite mixed scientific evidence on their effectiveness at improving health and reducing overdose deaths, 49 states and Washington, DC have adopted PDMPs, and they have received strong bipartisan legislative support. This article explores the history of PDMPs, tracking their evolution from paper-based administrative databases in the early 1900s to modern-day electronic systems that intervene at the point of care. We focus on two questions: how did PDMPs become so widely adopted in the United States, and how did they gain popularity as an intervention in the contemporary opioid crisis? Through this historical approach, we evaluate what PDMPs reflect about national drug policy and broader cultural understandings of substance use disorder in the United States today.
引用
收藏
页码:1191 / 1197
页数:7
相关论文
共 50 条
  • [31] Concurrent Use of Opioids and Benzodiazepines: Evaluation of Prescription Drug Monitoring by a United States Laboratory
    McClure, Fred Leland
    Niles, Justin K.
    Kaufman, Harvey W.
    Gudin, Jeffrey
    JOURNAL OF ADDICTION MEDICINE, 2017, 11 (06) : 420 - 426
  • [32] A prescription drug monitoring program, data sharing, and upholding states' rights under the United States Constitution
    Pehrson, Aimee
    Solla, Che A.
    Buehler, Jason
    Vance, Matthew
    JOURNAL OF PUBLIC HEALTH POLICY, 2023, 44 (01) : 102 - 109
  • [33] A prescription drug monitoring program, data sharing, and upholding states’ rights under the United States Constitution
    Aimee Pehrson
    Che A. Solla
    Jason Buehler
    Matthew Vance
    Journal of Public Health Policy, 2023, 44 (1) : 102 - 109
  • [34] Interprofessional education workshop for prescription drug monitoring programs
    Howard, Mitchell S.
    Bodi, Shirley M.
    Peeters, Michael J.
    MEDICAL EDUCATION, 2023, 57 (11) : 1161 - 1162
  • [35] Research to support optimization of prescription drug monitoring programs
    Doyle, Sheri
    Leichtling, Gillian
    Hildebran, Christi
    Reilly, Cynthia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 (11) : 1425 - 1427
  • [36] Prescription Drug Monitoring Programs and Opioid Death Rates
    Rudman, William, Jr.
    Corcoran, Peter
    Elliot, Kimberly
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (20): : 2044 - 2044
  • [37] Community Pharmacist Involvement in Prescription Drug Monitoring Programs
    Doong, Katie S.
    Gaccione, Daniella M.
    Brown, Todd A.
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2016, 8 (06) : 227 - 229
  • [38] EFFECT OF PRESCRIPTION DRUG MONITORING PROGRAMS ON TESTOSTERONE PRESCRIPTIONS
    Mulloy, E.
    Eisenberg, M.
    Li, S.
    JOURNAL OF SEXUAL MEDICINE, 2022, 19 (04): : S122 - S122
  • [39] Prescription drug monitoring programs, opioid abuse, and crime
    Dave, Dhaval
    Deza, Monica
    Horn, Brady
    SOUTHERN ECONOMIC JOURNAL, 2021, 87 (03) : 808 - 848
  • [40] Perceived Unintended Consequences of Prescription Drug Monitoring Programs
    Lai, Alden Yuanhong
    Smith, Katherine C.
    Vernick, Jon S.
    Davis, Corey S.
    Alexander, G. Caleb
    Rutkow, Lainie
    SUBSTANCE USE & MISUSE, 2019, 54 (02) : 345 - 349